breast-cancer-2017-scientifictracks-abstracts

6 / 12

Page 19
Notes:
allied
academies
J Med Oncl Ther 2017 | Volume 2 Issue 3
Breast Cancer November 01-02, 2017 | Toronto, Canada
7th World Congress on
Breast cancer in young women – retrospective study
Jana Slobodnikova
Alexander Dubcek University, Trencin
Breast cancer is themost commonmalignancy of the female
population the incidence is increasing mainly statistically
between 50s and 60s, 60s and 70s. Recently, however, we
meet more often with the occurrence of breast cancer in
women in 30s and significantly between 20 and 40 year. For
women this age range is not exist preventive or screening
mammography, in Slovakia only sonography and only clinical
self- examination by touch. In period from 1-5- 2005 and
30-6-2016 we performed more than 70 000 mammography
examinations and more than 185 000 ultrasound
examinations. The youngest patient was 6mons, the oldest
94 years. Patients were sent for examination by attending
gynecologist, general practitioner. Preventive examinations
completed asymptomatic women without clinical symptoms.
Young women and girls were examined by ultrasound
with 18 MHz linear probe, with CFM and elastography.
Next if necessary, we performed mammography, MR-
mammography a CCB too. During the monitored period we
diagnosed 398 new cases of the breast cancer, all cases are
verified by histopathology. The age distribution of patients
with newly diagnosed cancer we transparently stored in
tables and graphs. We focused on women in the age group to
39 and 49 year old. In category women between 18s and 39s
we diagnosed 32 new cases of breast cancer, between 40s
and 49s 64 cases. Summary are 86 of new cases of the breast
cancer in women between 18 and 49 years. We analyzed the
different findings, especially with respect to possibility of
diagnostic self-examination, combined with ultrasound, MR
mammography, mammography and core cut biopsy under
ultrasound control. The number of the young women with
new diagnosed breast cancer slowly increased. Our aim is the
early diagnostics, without vascular cancer vascular invasivity,
without the lymphadenopathy. We retrospectively focused
on genetic anamnesis factor, short time of the diagnosis and
therapy.
Speaker Biography
Jana Slobodnikova end study on Charles University in Prague., gradued -CSc/PhD/
completed at the age 38 years from Institute of Experimental Oncology Slovac Scientic
Academy. She is an Ass. Prof. in Trnaviensis University, Prof. Emeritus in St. Elizabeth
High Scool. She has lectured at several universities - Prague, Trenčín, Trnava and
Bratislava. She is the author of teaching script, university textbooks; she has lead
workshops, organize international congresses and workshops. She has published more
than 90 scientific papers, from then 25 papers in renowned journals and has been
serving as a 5 Editorial Board Member of repute. She has published three monography,
founded the section of breast imaging in 1996, from 1996 she is President of The
Section of Breast Imaging of Slovak Radiologic Society and Vice President of the
Slovak Society of Ultrasound in Medicine. Membership in organizations: ECR, EUSOBI,
EFSUMB, SSUM (Slovak Society of Ultrasound in Medicine) and SRS (Slovak Radiology
Society).
e: